🇺🇸 somatropine in United States

14 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 3 reports (21.43%)
  2. Headache — 2 reports (14.29%)
  3. Pain — 2 reports (14.29%)
  4. Accidental Exposure To Product — 1 report (7.14%)
  5. Arthralgia — 1 report (7.14%)
  6. Asthenia — 1 report (7.14%)
  7. Asthma — 1 report (7.14%)
  8. Blood Pressure Increased — 1 report (7.14%)
  9. Bone Disorder — 1 report (7.14%)
  10. Cardiac Disorder — 1 report (7.14%)

Source database →

Other Other approved in United States

Frequently asked questions

Is somatropine approved in United States?

somatropine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for somatropine in United States?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.